[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

MX2009003743A - Uso de ciclosporinas modificadas. - Google Patents

Uso de ciclosporinas modificadas.

Info

Publication number
MX2009003743A
MX2009003743A MX2009003743A MX2009003743A MX2009003743A MX 2009003743 A MX2009003743 A MX 2009003743A MX 2009003743 A MX2009003743 A MX 2009003743A MX 2009003743 A MX2009003743 A MX 2009003743A MX 2009003743 A MX2009003743 A MX 2009003743A
Authority
MX
Mexico
Prior art keywords
cyclosporins
modified
modified cyclosporins
prevention
treatment
Prior art date
Application number
MX2009003743A
Other languages
English (en)
Inventor
Motoyuki Kohjima
Makoto Nakamuta
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MX2009003743A publication Critical patent/MX2009003743A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Se dan a conocer ciclosporinas de enlace de ciclofilina no inmunosupresoras que tienen propiedades útiles en la prevención o el tratamiento de enfermedades hepáticas.
MX2009003743A 2006-10-12 2007-10-10 Uso de ciclosporinas modificadas. MX2009003743A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82922806P 2006-10-12 2006-10-12
PCT/EP2007/060794 WO2008043797A1 (en) 2006-10-12 2007-10-10 Use of modified cyclosporins

Publications (1)

Publication Number Publication Date
MX2009003743A true MX2009003743A (es) 2009-06-18

Family

ID=39092021

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009003743A MX2009003743A (es) 2006-10-12 2007-10-10 Uso de ciclosporinas modificadas.

Country Status (17)

Country Link
US (1) US20100130408A1 (es)
EP (1) EP2073831A1 (es)
JP (1) JP5455632B2 (es)
KR (1) KR20090083902A (es)
CN (1) CN101557819A (es)
AU (1) AU2007306316B2 (es)
BR (1) BRPI0719189A2 (es)
CA (1) CA2665415A1 (es)
IL (1) IL197966A0 (es)
MA (1) MA30865B1 (es)
MX (1) MX2009003743A (es)
NO (1) NO20091694L (es)
RU (1) RU2463071C2 (es)
SG (1) SG175621A1 (es)
TN (1) TN2009000135A1 (es)
WO (1) WO2008043797A1 (es)
ZA (1) ZA200902300B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110117055A1 (en) 2009-11-19 2011-05-19 Macdonald James E Methods of Treating Hepatitis C Virus with Oxoacetamide Compounds
CN101843893B (zh) * 2010-05-21 2012-02-01 中国人民解放军第三军医大学 环孢素a在制备抗轮状病毒药物中的应用
EP3351247A1 (en) * 2010-06-01 2018-07-25 Auspex Pharmaceutical, Inc. Benzoquinolone inhibitors of vmat2
US9550780B2 (en) 2012-09-18 2017-01-24 Auspex Pharmaceuticals, Inc. Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
JP6362601B2 (ja) 2012-09-18 2018-07-25 オースペックス・ファーマシューティカルズ・インコーポレイテッドＡｕｓｐｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． 小胞モノアミン輸送体２の重水素化ベンゾキノリン阻害剤の製剤薬物動態
MX369956B (es) 2013-12-03 2019-11-27 Auspex Pharmaceuticals Inc Metodos para preparar compuestos de benzoquinolina.
AU2016229949B2 (en) 2015-03-06 2021-04-08 Auspex Pharmaceuticals Llc Methods for the treatment of abnormal involuntary movement disorders

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639724A (en) * 1984-07-24 1997-06-17 Sandoz Ltd. Cyclosporin galenic forms
US5908621A (en) * 1995-11-02 1999-06-01 Schering Corporation Polyethylene glycol modified interferon therapy
FR2757522B1 (fr) * 1996-12-24 1999-01-29 Rhone Poulenc Rorer Sa Derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2757521B1 (fr) * 1996-12-24 1999-01-29 Rhone Poulenc Rorer Sa Nouveaux derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent
JPH1180026A (ja) * 1997-09-02 1999-03-23 Yoshitomi Pharmaceut Ind Ltd 新規免疫抑制剤、その使用方法およびその同定方法
US20030216303A1 (en) * 1998-03-06 2003-11-20 Michael Ambuhl Emulsion preconcentrates containing cyclosporin or a macrolide
CA2335903C (fr) * 1998-07-01 2009-11-10 Debiopharm S.A. Nouvelle cyclosporine ayant un profil d'activite ameliore
AU4144400A (en) * 1999-04-27 2000-11-10 Mitsubishi Pharma Corporation Preventives/remedies for liver diseases
JPWO2002030464A1 (ja) * 2000-10-11 2004-02-19 江頭 健輔 新規肝疾患用薬
US20030213603A1 (en) * 2002-05-14 2003-11-20 Fisher David B. Dual use extension apparatus for a tool
GB0320638D0 (en) * 2003-09-03 2003-10-01 Novartis Ag Organic compounds
US7079552B2 (en) * 2003-09-09 2006-07-18 Harris Corporation Mobile ad hoc network (MANET) with quality-of-service (QoS) protocol hierarchy and related methods
PT1793844E (pt) * 2004-10-01 2011-03-10 Debiopharm Sa Utilização de [d-meala]3-[etval]4-csa para o tratamento de infecção causada pelo vírus da hepatite c
ATE530561T1 (de) * 2004-10-01 2011-11-15 Scynexis Inc 3-ether- und 3-thioether-substituierte ciclosporinderivate zur behandlung und prävention einer hepatitis-c-infektion
CA2587793A1 (en) * 2004-12-23 2006-07-06 Novartis Ag Compositions for hcv treatment
US8512690B2 (en) * 2009-04-10 2013-08-20 Novartis Ag Derivatised proline containing peptide compounds as protease inhibitors

Also Published As

Publication number Publication date
EP2073831A1 (en) 2009-07-01
NO20091694L (no) 2009-07-10
WO2008043797A1 (en) 2008-04-17
BRPI0719189A2 (pt) 2018-08-14
JP5455632B2 (ja) 2014-03-26
ZA200902300B (en) 2010-10-27
CA2665415A1 (en) 2008-04-17
RU2009117699A (ru) 2010-11-20
JP2010505912A (ja) 2010-02-25
AU2007306316B2 (en) 2011-10-27
IL197966A0 (en) 2011-08-01
SG175621A1 (en) 2011-11-28
MA30865B1 (fr) 2009-11-02
TN2009000135A1 (en) 2010-10-18
US20100130408A1 (en) 2010-05-27
KR20090083902A (ko) 2009-08-04
AU2007306316A1 (en) 2008-04-17
RU2463071C2 (ru) 2012-10-10
CN101557819A (zh) 2009-10-14

Similar Documents

Publication Publication Date Title
TNSN07240A1 (en) Compounds for flaviviridae treatment
TNSN06071A1 (en) Use of modified cyclosporins for the treatment of hcv disorders
MY158325A (en) Multitype peptide compositions and methods for treatment or prevention of human papillpmavirus infection
TN2009000135A1 (en) Use of modified cyclosporins
CL2007002261A1 (es) Compuestos derivados de imidazo[1,2-b]piridazina, inhibidores de quinasa; composicion farmaceutica; y uso en el tratamiento o prevencion del cancer.
WO2007001851A3 (en) Compositions and methods for the diagnosis and treatment of tumor
MX2012009748A (es) USO DE PEPTIDOS INHIBIDORES DEL FACTOR DE CRECIMIENTO TRANSFORMANTE-BETA1(TGF-ß1) PARA EL TRATAMIENTO DE FIBROSIS Y/U OPACIDAD CORNEAL.
MX356129B (es) Peptidos y analogos de peptidos protectores de los tejidos para evitar y tratar padecimientos y desordenes asociados con daño de los tejidos.
MX348797B (es) Microorganismos probioticos como agentes activos para mejorar el brillo de la tez de la piel.
MY147247A (en) Organic compounds and their uses
MX2009013729A (es) Imidazopirazinas como inhibidores de proteina quinasa.
PL1986669T3 (pl) Zastosowanie Bifidobacterium longum do zapobiegania i leczenia zapalenia
WO2010034032A3 (en) Methods for preparing purified polypeptide compositions
MX2010001779A (es) Peptidos para vacunas.
PL1854477T3 (pl) Peptydy hamujące kalikreinę osoczową do zastosowania w leczeniu zaburzeń okulistycznych
UA91848C2 (ru) Применение соединений диосметина в лечении и предотвращении тромботическим патологиям
WO2008014200A3 (en) Cyclosporin compositions
WO2006116221A3 (en) Therapeutic combinations for the treatment or prevention of psychotic disorders
MX2010003045A (es) Composiciones de ciclosporina.
IL186325A0 (en) Tizanidine compositions and methods of treatment using the compositions
BRPI0513317A (pt) ciclosporinas para tratar doença de alzheimer
TW200735886A (en) Prevention and treatment of ocular side effects with a cyclosporin
WO2008078167A3 (en) Consensus peptide
BRPI0509690A (pt) nim811 na isquemia cerebral e danos cerebrais e na medula espinhal
WO2009074253A3 (en) Clofarabine dietherphospholipid derivatives

Legal Events

Date Code Title Description
FG Grant or registration